May 28, 2020

Securing the success of Healthcare and Life Sciences M&A in APAC

Accelerate due diligence in the healthcare and life sciences sectors in APAC

 

The healthcare sector is rich with opportunity. But to take advantage of these opportunities, you need to track and control a complex exchange of information. There are stronger-than-ever data privacy requirements and industry regulations. 

This means staying on top of due diligence best practices has never been more important for dealmakers in your industry.

Datasite supported more than half the billion-dollar life sciences deals in 2019. Which means that we helped M&A professionals like you create successful deals when the stakes were high.

Download this white paper and gain insight into how you can stay on top of your deals while keeping sensitive IP and patient data secure.

Ready to Get Started?

You may also like:

The New State of M&A: Central and Eastern Europe

Most CEE M&A practitioners believe that due diligence – the most time-consuming phase of the M&A process – could be enhanced most by new technologies and digitization. Which technologies could help and in what other areas?

The New State of M&A: Brazil

Download our new report about M&A in Brazil and get valuable insights into the present and future of due diligence, asset marketing and automation.

TTR Iberian Market - May 2021 Report

TTR's May M&A Report covering Portugal indicates a 10% decline in transaction volume compared to 2020 and EUR 3.71bn aggregate value. Read the report to find out more details about the state of M&A in Iberia.